The writer of this article is an ex-nurse and
ex-pharmaceutical employee. The science behind hydroxychloroquine for
the treatment of covid-19 has become enmeshed in confusion, with many
studies investigating this drug alone but not in combination with the
'worker' zinc. This age-old anti-malarial can facilitate the penetration
of zinc (and vit. c) through the virus cell wall in order for the
latter to kill the virus. When used in conjunction, not alone, the
results have been very good indeed. This treatment has not been used in
many Western countries due to lack of clinical evidence or potential
cardiac problems - in fact it was banned in France and the UK, among
others. Often, drugs can be used off-licence if a doctor deems benefit
outweighs risk, and this one has been prescribed for malarial prevention
for decades. However, there were few studies.
We found many articles where hydroxychloroquine when used in conjunction with zinc,
plus an antibiotic for the secondary pulmonary infection, significantly
reduced mortality. There is evidence emerging from 'jobbing' doctors to
show that early intervention increases a positive outcome even more
(note the video in the vaccine post and page from Texas). Have a look at
this article from India. Indian doctors did use this combination early
on and India has suffered far fewer casualties than the Western world...
However, our media was quick to shun the information and condemn it as
dangerous.
Other existing, free treatments.... Dr Jack Kruse, a US neurosurgeon we will refer to again in the 5G and emf post, out next week, draws attention to a simple t-cell stimulating agent - the sun. This was published data back in 2016. But guess what - the new vaccine you 'need' for covid, is better than your antibodies because it stimulates t-cells.
Another point - there is much talk and indeed a trial, for the prophylactic use of hydroxychloroquine. Prophylactic use is for malaria. Some articles suggest taking hydroxychloroquine prophylactically can cause damage the immune system. It doesn't seem at all a sensible route to take, and we at EchoBlue don't condone taking it long term for prevention. However, from what doctors on the ground are finding, the combination treatment regime is proving valuable if a patient is hospitalised and facing a ventilator. They've had good results in that situation. See the link to the Texan doctors' findings on the New Information page!
Kindest wishes!
